Archive

Faceted archive

267 documents matching

This week
IN FORCE CDSCO · Circular · 2027-04-03
24 Withdrawal / cancellation of product permission for not Implementing of GSR 327 (E) dated 03.04.2027 for obtaining result of bio-equivalence study before grant of manufacturing license of oral dosa
June 2026
IN FORCE CDSCO · Public Notice · 2026-06-29
1 CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026 2026-Jun-29 661 KB
April 2026
IN FORCE CDSCO · Public Notice · 2026-04-22
8 COVID-19 vaccines approved in the country as on 22.04.2026 2026-Apr-23 536 KB
Biological E. Ltd.Cipla Ltd.
March 2026
IN FORCE CDSCO · Public Notice · 2026-03-13
14 Addendum to Doc No. CDSCO. IVD. FAQ. 04. 2022 dated 13.03.2026 2026-Mar-13 321 KB
January 2026
IN FORCE CDSCO · Circular · 2026-01-20
9 Implementation of Prior intimation System for Forms CT-10, CT-12 and CT-13 in pursuance of G.S.R. 46(E) dated 20.01.2026 2026-Mar-06 57 KB
August 2025
IN FORCE CDSCO · Public Notice · 2025-08-11
55 COVID-19 vaccines approved in the country as on 11.08.2025 2025-Aug-11 477 KB
Biological E. Ltd.Cipla Ltd.
July 2025
IN FORCE CDSCO · Circular · 2025-07-21
31 Training schedule for the grant of WHO GMP (COPP) through ONDLS portal to be conducted from 21.07.2025 to 13.08.2025 by zonal and sub Zonal Office CDSCO 2025-Jul-18 813 KB
June 2025
IN FORCE CDSCO · Public Notice · 2025-06-04
66 CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 04.06.2025 2025-Jun-04 617 KB
April 2025
IN FORCE CDSCO · Public Notice · 2025-04-11
49 Corrigendum to the letter dated 11.04.2025 on manufacturing and marketing of unapproved FDCs 2025-Sep-10 433 KB
March 2025
IN FORCE CDSCO · Circular · 2025-03-27
44 OM dated 27.03.2025 regarding Exemption of sampling and testing of orphan drugs at CDSCO Port office 2025-Mar-27 62 KB
IN FORCE CDSCO · Public Notice · 2025-03-12
80 PAC Cancellation letter dated 12.03.2025 FSN brands Marketing Pvt Ltd 2025-Mar-12 257 KB
Amendment in the RC No. RC/COS-002272 valid upto 03-Mar-2026 of the Cosmetics
Fsn Brands Marketing Pvt. Ltd.
April 2024
IN FORCE CDSCO · Public Notice · 2024-04-22
110 Stakeholder consultation for feedback on SEC meetings dated 22.04.2024 2024-Apr-22 272 KB
IN FORCE CDSCO · Public Notice · 2024-04-15
103 Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 2nd and 4th July 2024 Meeting cancellation 2024-Jul-01 176 KB
IN FORCE CDSCO · Public Notice · 2024-04-15
112 Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 18 April 2024 Meeting cancellation 2024-Apr-15 143 KB
IN FORCE CDSCO · Circular · 2024-04-12
68 Office Memorandum dated 12.04.2024 Grievance Redressal Officer for redressing the grievances of Persons with Disabilities under Section 23 of RPWD Act 2016 for CDSCO 2024-Apr-12 186 KB
IN FORCE CDSCO · Public Notice · 2024-04-08
114 Public Notice regarding DCGI meeting with Stakeholders Dated 08.04.2024 for 16 April 2024 Meeting cancellation 2024-Apr-08 142 KB
IN FORCE CDSCO · Public Notice · 2024-04-05
118 Meeting through WebEx Video-conference of the DTAB-sub Committee on 05.04.2024 at 11.00 a.m. to 6:00 p.m. to Evaluation of 16 FDCs which were earlier considered as irrational in the Expert Committ
March 2024
IN FORCE CDSCO · Public Notice · 2024-03-26
117 Public Notice regarding DCGI meeting with Stakeholders Dated 26.03.2024 for 28 march 2024 Meeting cancellation 2024-Mar-26 142 KB
IN FORCE CDSCO · Public Notice · 2024-03-06
120 Public Notice regarding DCGI meeting with Stakeholders Dated 06.03.2024 2024-Mar-06 106 KB
February 2024
IN FORCE CDSCO · Public Notice · 2024-02-26
122 Public Notice No. Admin-A012(12)/46/2024-eoffice dated 26.02.2024 2024-Feb-26 63 KB
IN FORCE CDSCO · Public Notice · 2024-02-15
123 Public Notice dated 15.02.2024 2024-Feb-14 568 KB
January 2024
IN FORCE CDSCO · Public Notice · 2024-01-31
125 SEC-IND Office order dated 31.01.2024 2024-Jan-31 182 KB
October 2023
IN FORCE CDSCO · Circular · 2023-10-01
88 Regulation of all Class C & D Medical Devices Under Licensing regime, w.e,f 01.10.2023 as per GSR102E dated 11.02.2020 2023-Oct-12 385 KB
September 2023
IN FORCE CDSCO · Public Notice · 2023-09-26
144 CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 26.09.2023 2023-Sep-29 654 KB
July 2023
IN FORCE CDSCO · Circular · 2023-07-18
106 Reconstitution of Internal Complaint Committee on Sexual Harassment dated 18.07.2023 2023-Jul-18 423 KB
IN FORCE CDSCO · Circular · 2023-07-03
107 Transfer Policy for the officers/officials of CDSCO dated 03.07.2023 2023-Jul-03 69 KB
Transfer Policy for the officers/officials of CDSCO
June 2023
IN FORCE CDSCO · Circular · 2023-06-14
108 Transfer order of DDC(I) dated 14.06.2023 2023-Jun-14 1066 KB
January 2023
IN FORCE CDSCO · Public Notice · 2023-01-25
162 Rapid / CLIA / ELISA Kits approved for testing of Covid-19 as on 25.01.2023 2023-Jan-25 540 KB
CPC Diag. Pvt. Ltd.ImmunoshopIndia Pvt. Ltd.Athenese Dx Pvt. Ltd.
IN FORCE CDSCO · Public Notice · 2023-01-25
163 PCR Kits approved for testing of Covid-19 as on 25.01.2023 2023-Jan-25 512 KB
Lab Genomics Co. Ltd.Life TechnologiesAthenese Dx Pvt. Ltd.
September 2022
IN FORCE CDSCO · Public Notice · 2022-09-30
170 Notice regarding implementation of gazette notification vide GSR 754(E) dated 30.09.2022 2022-Sep-30 290 KB
IN FORCE CDSCO · Public Notice · 2022-09-26
72 Examination of 2nd assessment report of Prof. Kokate Committee by Drugs Technical Advisory Board (DTAB) in its meeting dated 26.09.2022 2025-Apr-11 3102 KB
April 2022
IN FORCE CDSCO · Public Notice · 2022-04-29
79 Surrender of lmport Registration Certificate under Cos-4A vide IRN/COS- 4N20221 000001 dated 29.04.2022 and I RN/COS- 4N20221 000006 dated 14.08.2022 2025-Mar-27 371 KB
NKG Advisory Business and Consulting Services Pvt. Ltd.NK Healthcare Pvt. Ltd.
March 2022
IN FORCE CDSCO · Public Notice · 2022-03-25
136 Surrender and Cancellation of Cosmetics Registration Certificate No. RC/COS-003067 dated 25.03.2022 (M/s. Abbott Health Care P Ltd) 2023-Nov-28 325 KB
Abbott Healthcare Pvt. Ltd.
February 2022
IN FORCE CDSCO · Public Notice · 2022-02-11
192 Rapid / CLIA / ELISA Kits approved for testing of Covid-19 as on 11.02.2022 2022-Feb-11 510 KB
CPC Diag. Pvt. Ltd.ImmunoshopIndia Pvt. Ltd.Athenese Dx Pvt. Ltd.
December 2021
IN FORCE CDSCO · Public Notice · 2021-12-10
195 Publice Notice dated 10.12.2021 2021-Dec-10 169 KB
IN FORCE CDSCO · Public Notice · 2021-12-09
196 PCR Kits approved for testing of Covid-19 as on 09.12.2021 2021-Dec-09 479 KB
Lab Genomics Co. Ltd.Life TechnologiesAthenese Dx Pvt. Ltd.
April 2017
IN FORCE CDSCO · Circular · 2017-04-09
176 Merit List based on the written examination held on 09.04.2017 at NIB Noida for WHO Roational Fellowhip Selection 2017-Apr-10 3,500kb
August 2014
IN FORCE CDSCO · Circular · 2014-08-29
206 Postponement of the Seventh Expert Committee Meeting from 29.08.2014 to 05.09.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permi
Restech PharmaNOEL PharmaRexer Pharma
IN FORCE CDSCO · Circular · 2014-08-29
200 Seventh Meeting of the Expert Committee on 29.08.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale
Glenmark PharmaceuticalsSavi Pharrns Ltd.
IN FORCE CDSCO · Circular · 2014-08-27
205 Sixth Meeting of the Expert Committee on 27.08.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale i
Aurochem Laboratories (fF) Pvt. Ltd.Sun PharmaceuticalsGlenmark Pharmaceuticals
Undated
IN FORCE CDSCO · Circular · undated
1 Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms 2026-Jul-06 53 KB
IN FORCE CDSCO · Public Notice · undated
95 Inviting comments on standard IVD evaluation protocols drafted by ICMR and CDSCO 2025-Jan-02 2843 KB
IN FORCE CDSCO · Circular · undated
1 Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets 2026-Jun-24 758 KB
IN FORCE CDSCO · Public Notice · undated
2 List of Suspended Ethics Committee by CLA 2026-Jun-12 1584 KB
para-2.4.2
IN FORCE CDSCO · Public Notice · undated
100 Approved panel of experts for the Subject Expert Committees 2024-Aug-29 493 KB
IN FORCE CDSCO · Public Notice · undated
196 Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority 2021-Dec-28 123 KB
IN FORCE CDSCO · Public Notice · undated
1 List of Debarment of Principal Investigators by CLA 2026-Jun-12 2691 KB
para-2.4.2 Healthcare Global Enterprises
IN FORCE CDSCO · Circular · undated
1 Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO 2026-Jun-16 134 KB
IN FORCE CDSCO · Public Notice · undated
18 Testing Laboratories approved by Statas & UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020 2026-Mar-10 455 KB
HS 88 Analys Lab Pvt. Ltd.Biocon Biosphere Ltd.Chalapathi institute of Pharmaceutical
IN FORCE CDSCO · Circular · undated
1 Submission of Compliance for lmported/manufactured Hair Color Cosmetics Products as per Cosmetics Rules, 2020 and applicable BIS Standards 2026-Jun-11 350 KB
Page 1 / 6 Next →